Roberto Trevisan

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.7K citations · Full text

Diabetes Management, Cardiovascular Disease, Diabetes +6

Preventing Microalbuminuria in Type 2 Diabetes

Piero Ruggenenti, Anna Fassi, Simona Bruno et al. · New England Journal of Medicine · 2004 · 1K citations · Full text

Glomerular Hyperfiltration and Renal Disease Progression in Type 2 Diabetes

Piero Ruggenenti, Esteban Porrini, Flavio Gaspari et al. · Diabetes Care · 2012 · 313 citations · Full text

Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial

Olga Vaccaro, Maria Masulli, Antonio Nicolucci et al. · The Lancet Diabetes & Endocrinology · 2017 · 285 citations

Diabetes Management, Cardiovascular Disease, Diabetes +9

Renal, metabolic and hormonal responses to ingestion of animal and vegetable proteins

Panayotis Kontessis, S. L. Jones, Rosemary Dodds et al. · Kidney International · 1990 · 275 citations · Full text

Animal Physiology, Nutrition, Biochemistry +12